Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CStone Pharmaceuticals ( (HK:2616) ) has issued an announcement.
CStone Pharmaceuticals has announced its Annual General Meeting (AGM) scheduled for June 25, 2025, in Shanghai, China. The AGM will address several key resolutions, including the re-election of board members, the authorization of director remuneration, and the reappointment of Deloitte Touche Tohmatsu as the company’s auditor. Additionally, the meeting will consider a resolution to authorize the board to issue new shares, subject to certain conditions, which could impact the company’s financial strategy and shareholder value.
More about CStone Pharmaceuticals
CStone Pharmaceuticals is a biopharmaceutical company incorporated in the Cayman Islands, primarily focused on the development and commercialization of innovative immuno-oncology and precision medicine therapies. The company operates in the pharmaceutical industry with a market focus on cancer treatment solutions.
Average Trading Volume: 8,443,229
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.55B
For an in-depth examination of 2616 stock, go to TipRanks’ Stock Analysis page.